GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.585
-0.120 (-7.04%)
Nov 16, 2026, 10:11 AM EST - Market open
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $600.57 thousand as of November 16, 2026. It is the 50,077th most valuable company in the world and the 6,805th biggest in the United States. Its market cap has decreased by 95.52% in one year.
Market Cap
600.57K
Enterprise Value
-1.30M
1-Year Change
-95.52%
Global Rank
Country Rank
#6,805 United States
Category
ChartMarket Cap Chart
Since November 1, 2019, GeoVax Labs's market cap has increased from $535.71K to $600.57K, an increase of 12.11%. That is a compound annual growth rate of 1.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 600.57K | -91.82% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.15% |
| Dec 31, 2021 | 23.10M | 92.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Artelo Biosciences | 1.13M |
| Bone Biologics | 1.10M |
| Oragenics | 906.90K |
| Matinas BioPharma Holdings | 881.57K |
| SciSparc | 869.84K |
| Lakewood-Amedex Biotherapeutics | 669.20K |
| Decoy Therapeutics | 638.94K |
| Scinai Immunotherapeutics | 541.29K |